Cargando…
Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
There has been an increasing trend in the number of prescribed and over-the-counter drug recall over the last few years. The recall is usually due to company's discovery, customer's complaint or Food and Drug Administration (FDA) observation. The process of recall involves a planned specif...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286830/ https://www.ncbi.nlm.nih.gov/pubmed/25599028 http://dx.doi.org/10.4103/2230-973X.147222 |
_version_ | 1782351714523807744 |
---|---|
author | Nagaich, Upendra Sadhna, Divya |
author_facet | Nagaich, Upendra Sadhna, Divya |
author_sort | Nagaich, Upendra |
collection | PubMed |
description | There has been an increasing trend in the number of prescribed and over-the-counter drug recall over the last few years. The recall is usually due to company's discovery, customer's complaint or Food and Drug Administration (FDA) observation. The process of recall involves a planned specific course of action, which addresses the depth of recall, need for public warning, and the extent of effectiveness checks for the recall. The FDA review and/or recommend changes to the firm's recall strategy, as appropriate. The critical recall information list includes the identity of the product; summary of the failure; amount of product produced in the distribution chain and direct account. Product recalls clashes thousands of companies every year affecting: sales, testing customer relationships and disrupting supply chains. Drug recall is incubus for pharmaceutical companies. It effects the reputation of the company. The reason for the recall can be divided into two categories: manufacturing affined and safety/efficacy affined. It is essential to follow all the guidelines related to drug development and manufacturing procedure so as to minimize drug recall. |
format | Online Article Text |
id | pubmed-4286830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42868302015-01-16 Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history Nagaich, Upendra Sadhna, Divya Int J Pharm Investig Review Article There has been an increasing trend in the number of prescribed and over-the-counter drug recall over the last few years. The recall is usually due to company's discovery, customer's complaint or Food and Drug Administration (FDA) observation. The process of recall involves a planned specific course of action, which addresses the depth of recall, need for public warning, and the extent of effectiveness checks for the recall. The FDA review and/or recommend changes to the firm's recall strategy, as appropriate. The critical recall information list includes the identity of the product; summary of the failure; amount of product produced in the distribution chain and direct account. Product recalls clashes thousands of companies every year affecting: sales, testing customer relationships and disrupting supply chains. Drug recall is incubus for pharmaceutical companies. It effects the reputation of the company. The reason for the recall can be divided into two categories: manufacturing affined and safety/efficacy affined. It is essential to follow all the guidelines related to drug development and manufacturing procedure so as to minimize drug recall. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4286830/ /pubmed/25599028 http://dx.doi.org/10.4103/2230-973X.147222 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Nagaich, Upendra Sadhna, Divya Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history |
title | Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history |
title_full | Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history |
title_fullStr | Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history |
title_full_unstemmed | Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history |
title_short | Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history |
title_sort | drug recall: an incubus for pharmaceutical companies and most serious drug recall of history |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286830/ https://www.ncbi.nlm.nih.gov/pubmed/25599028 http://dx.doi.org/10.4103/2230-973X.147222 |
work_keys_str_mv | AT nagaichupendra drugrecallanincubusforpharmaceuticalcompaniesandmostseriousdrugrecallofhistory AT sadhnadivya drugrecallanincubusforpharmaceuticalcompaniesandmostseriousdrugrecallofhistory |